Détails Publication
Metastatic Prostate Cancers at the University Hospital Center-Bogodogo (CHU-B) in OUAGADOUGOU : Situation in a Resource-Limited Country like Burkina Faso,
Discipline: Médecine clinique
Auteur(s): Bambara Hierrhum Aboubacar, Zerbo Nina Assanatou, Nikiema Liliane Marie, Kabore Fasnewinde Aristide, Valerie Odero-Marah
Renseignée par : BAMBARA Hierrhum Aboubacar
Résumé

Prostate cancer is the leading cancer in men in Burkina Faso, contributing to an incidence rate of 26.3%, according to
GLOBOCAN 2020. Metastatic prostate cancer (mPC) makes up about 30% of prostate cancer cases. Our objective was to examine the epidemiological, diagnostic, and treatment characteristics of mPC hospitalized and non-hospitalized instances within the Clinical Oncology and Hematology Department of the University Hospital Center-Bogodogo (CHU-B). This study adopted a descriptive cross-sectional approach, encompassing retrospective data acquisition from May 1, 2017, to April 30, 2020. All patients undergoing follow-up for mPC, with confirmed histological diagnosis and metastatic verification supported by clinical, radiological, and/or histological evidence, were included. Data was collected from individual records within patients’ clinical files. mPC comprised 76.6% of the diagnosed prostate cancer cases. The average age was 67.7 years [range: 50 to 89 years]. The typical interval before consultation was 29.7 months. Urinary symptoms were present in 87.7% of cases, while bone pain was reported in 75.5% of cases. Secondary bone involvement was identified in 78.26% of instances. The mean total PSA level was 1179.28 ng/ml, [range: 7 to 9976 ng/ml]. The complete androgen blockade protocol was utilized for treatment in 69.3% of patients, with the Docetaxel protocol being employed in 26.5% of cases. The median survival duration was 8.13 months. mPC was predominant among prostate cancers, underscoring the urgency of promptly implementing Burkina Faso’s strategic plan for cancer control.

Mots-clés

Metastatic Prostate Cancer, CHU Bogodogo, Burkina Faso, Early Screening and Detection, Treatment Characteristics

930
Enseignants
5641
Publications
49
Laboratoires
84
Projets